SBI PO 2025: 600 vacancies announced for recruitment Preliminary exam scheduled from March 8-15, 2025 Applications open Dec 27; deadline is Jan 16, 2025 The SBI PO 2025 recruitment notification has ...
SBI PO 2024 application fee is ₹750 for unreserved, EWS and OBC candidates. There is no application fee for SC, ST and PwBD candidates. Check the detailed notification here for further information.
SBI PO Recruitment 2024: A total of 600 vacancies will be filled through this recruitment drive. This includes 586 regular posts and 14 backlog vacancies. SBI PO Recruitment 2024: The application ...
The State Bank of India (SBI) has announced the recruitment of 600 Probationary Officers (PO) for 2025. The application process starts on December 27, 2025, and ends on January 16, 2025.
State Bank of India has declared the SBI PO 2025 Exam Date. The preliminary exam for SBI PO 2025 will be held on 08 and 15 March 2025 while the mains will be in April/May 2025. Aspirants who qualify ...
No: CRPD/PO/2024-25/22. Eligible candidates can apply for the posts at sbi.co.in from December 27 onwards. The last date to submit the form is January 16, 2025. The Preliminary exam will be ...
Starring Jude Law, Nicholas Hoult, Tye Sheridan, Jurnee Smollett, Morgan Holmstrom, Alison Oliver, Marc Maron, Odessa Young, George Tchortov, Daniel Doheny, Sebastian ...
SBI PO Recruitment Notification 2024-25: The State Bank of India (SBI) has recently issued the notification for the employment of the 600 Probationary Officers. The notification is released on 26 ...
The Director General of the Ghana Standards Authority, Prof. Alex Duodoo, has emphasised the need for vigilance as unapproved products continue to infiltrate the market. He said that despite ...
Jason Steele is a Senior Points and Miles Contributor who has been writing for The Points Guy since 2012. An expert in credit cards and award travel, Jason travels frequently across the United States ...
"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said ...